Mineralys Therapeutics, Inc. (MLYS) earnings
MLYS earnings moved a median of +0.37% by the close. Quarterly and annual MLYS reports and results, each read against the price at its own news timestamp. Back to the MLYS overview →
31 measured MLYS earnings events.
Where these MLYS earnings landedvs 31 measured MLYS earnings reactions
| Middle 50% of MLYS earnings reactions | -1.81% to +2.30% |
|---|---|
| Median reaction (to close) | +0.37% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 MLYS earnings events with a measured close landed between -1.81% and +2.30%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Mineralys Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.40% | +7.68% | |
| Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +4.40% | +7.68% | |
| Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026 | Press release | -0.17% | +1.15% | |
| Form 10-Q Mineralys Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.27% | +0.58% | |
| Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.27% | +0.58% | |
| Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 | Press release | +1.41% | +3.13% | |
| Form 10-K Mineralys Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.53% | +1.47% | |
| Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update | Press release | +4.53% | +1.47% | |
| Form 10-Q Mineralys Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.11% | +12.17% | |
| Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +1.11% | +12.17% | |
| Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 | Press release | +1.19% | -1.68% | |
| Form 10-Q Mineralys Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.09% | +3.43% | |
| Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.09% | +3.43% | |
| Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025 | Press release | +0.85% | +3.63% | |
| Form 10-Q Mineralys Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.97% | +1.27% | |
| Mineralys Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.97% | +1.27% | |
| Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025 | Press release | +0.10% | -6.59% | |
| Form 10-K Mineralys Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.50% | +0.19% | |
| Form 10-Q Mineralys Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.22% | -0.96% | |
| Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.22% | -0.96% | |
| Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024 | Press release | +0.00% | +0.37% | |
| Form 10-Q Mineralys Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.43% | -18.19% | |
| Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -1.43% | -18.19% | |
| Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024 | Press release | -1.39% | +0.18% | |
| Form 10-Q Mineralys Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.24% | -2.79% | |
| Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.24% | -2.79% | |
| Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024 | Press release | -0.57% | +0.00% | |
| Form 10-K Mineralys Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.70% | -1.95% | |
| Form 10-Q Mineralys Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.69% | -6.74% | |
| Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | +0.69% | -6.74% | |
| Mineralys Therapeutics to Announce Third Quarter 2023 Financial Results and Host Conference Call on Tuesday, November 7, 2023 | Press release | +0.00% | -0.90% |
Keep exploring
More MLYS: analyst actions → · SEC filings → · MLYS overview →